Dr Lalchandani Labs Ltd.
BSE: 541299
₹9.80
₹-0.45
(-4.39%)
As on 22-May-2026IST
Market cap
₹8 Cr
Revenue (TTM)
₹4 Cr
P/E Ratio
20.3
P/B Ratio
0.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
4.3 %
-
ROCE
3.6 %
-
Industry P/E
--
-
EV/EBITDA
9.9
-
Debt to Equity
0.4
-
Book Value
₹17
-
EPS
₹0.7
-
Face value
10
-
Shares outstanding
8,637,068
8 Years Aggregate
CFO
₹3.38 Cr
EBITDA
₹8.97 Cr
Net Profit
₹2.69 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Dr Lalchandani Lab
| -36.3 | 2.2 | -- | 10.8 | -19.8 | -14.0 | -- |
|
BSE Healthcare
| 8.8 | 8.8 | 9.7 | 11.0 | 27.5 | 14.1 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Dr Lalchandani Lab
| 23.1 | -20.2 | -22.7 | -32.5 | 198.5 | 12.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
9.8 | 8.5 | 4.5 | 0.4 | -- | 4.3 | 20.3 | 0.6 |
| 113.4 | 116.7 | 24.2 | 1.5 | 5.5 | 11 | 79.6 | 9.1 | |
| 756.6 | 39,185.5 | 4,643.2 | 464.1 | 13.7 | 8.9 | 101 | 8.6 | |
| 1,630.1 | 27,275.5 | 2,762.9 | 509.8 | 22.5 | 21.5 | 54 | 10.9 | |
| 12.2 | 12.8 | 0.6 | 0.2 | -- | 0.8 | -- | 0.5 | |
| 764.1 | 30,572.6 | 3,904.6 | 239.4 | 13.3 | 11.1 | 126.6 | 13.6 | |
| 109.2 | 222.6 | 51.6 | 0.7 | 1.3 | 1.1 | 340.9 | 3.7 | |
| 116.9 | 39.2 | 16.5 | -1.4 | 6.6 | -3.6 | -- | 1.0 | |
| 16.3 | 37.0 | 0.0 | -8.7 | -- | -64.3 | -- | 3.2 | |
| 73.0 | 31.1 | 27.2 | -2.0 | -3.4 | -287.5 | -- | -29.8 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Dr Lalchandani Lab
Hospital activities
-
Incorporated
2011
-
Chairman
Arjan Lalchandani
-
Managing Director
Arjan Lalchandani
-
Headquarters
New Delhi, Delhi
-
Website
Looking for more details about Dr Lalchandani Labs Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsReply To The Clarification Sought By BSE
13-Apr-2026Approval Of Basis Of Allotment Under Right Issue
02-Mar-2026No News & Announcements are available.
FAQs for Dr Lalchandani Lab
What is the current share price of Dr Lalchandani Labs Ltd Today?
The share price of Dr Lalchandani Labs Ltd is ₹9.80 (BSE) as of 22-May-2026 IST. Dr Lalchandani Labs Ltd has given a return of -19.8% in the last 3 years.
What is the current PB & PE ratio of Dr Lalchandani Labs Ltd?
The P/E ratio of Dr Lalchandani Labs Ltd is 20.29 times as on 22-May-2026.
The P/B ratio of Dr Lalchandani Labs Ltd is 0.59 times as on 22-May-2026, a 72 discount to its peers’ median range of 2.08 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
10.61
|
0.45
|
|
2024
|
11.02
|
0.71
|
|
2023
|
0.00
|
1.38
|
|
2022
|
15.32
|
1.38
|
|
2021
|
5.96
|
0.65
|
What is the 52 Week High and Low of Dr Lalchandani Labs Ltd?
The 52-week high and low of Dr Lalchandani Labs Ltd are Rs 21.22 and Rs 8.15 as of 22-May-2026.
What is the market cap of Dr Lalchandani Labs Ltd?
Dr Lalchandani Labs Ltd has a market capitalisation of ₹ 8 Cr as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Dr Lalchandani Labs Ltd?
Before investing in Dr Lalchandani Labs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.